InspireMD
NSPR
4 hedge funds and large institutions have $55K invested in InspireMD in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 6 closing their positions.
0% less ownership
Funds ownership: 0.01% → 0% (-0%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
60% less funds holding
Funds holding: 10 → 4 (-6)
80% less capital invested
Capital invested by funds: $269K → $55K (-$214K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$24.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$89K |
| 2 |
Renaissance Technologies
New York
|
-$62K |
| 3 |
VF
Virtu Financial
New York
|
-$46K |
| 4 |
Barclays
London,
United Kingdom
|
-$26K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$2.97K |
NSPR Hedge Fund Activity: Q1 2019 in Review
4 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q1 2019, worth a combined $55K — down 80% from $269K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of NSPR and 0 opened new positions — a net loss of 6 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Panagora Asset Management, adding an estimated $24.8K. The largest seller was Sabby Management, exiting entirely with an estimated $89K sold.
- 4 institutional investors held InspireMD (NSPR) as of Q1 2019, down from 10 in Q4 2018.
- Funds reported $55K of InspireMD stock for Q1 2019, down 80% quarter-over-quarter.
- 0 funds opened new InspireMD positions in Q1 2019 and 6 closed out, a net change of -6 holders.
- The largest InspireMD buyer in Q1 2019 was Panagora Asset Management, an estimated $24.8K added.
- The largest InspireMD seller in Q1 2019 was Sabby Management, an estimated $89K sold.
Based on aggregated 13F filings for Q1 2019.